title: Relationships of adrenoceptor polymorphisms with obesity.
abstract: Obesity, hypertension, and type 2 diabetes are rapidly growing public health problems. Heightened sympathetic nerve activity is a well-established observation in obesity, hypertension, and type 2 diabetes. Human obesity, hypertension, and diabetes have strong genetic as well as environmental determinants. Reduced energy expenditure and resting metabolic rate are predictive of weight gain, and the sympathetic nervous system participates in regulating energy balance through thermogenesis. The thermogenic effects of catecholamines in obesity are mainly mediated via the β2, and β3-adrenergic receptors in humans. Further, β2-adrenoceptors importantly influence vascular reactivity and may regulate blood pressure. β-adrenoceptor polymorphisms have also been associated with adrenoceptor desensitization, increased adiposity, insulin resistance, and enhanced sympathetic nervous activity. Many epidemiological studies have shown strong relationships between adrenoceptor polymorphisms and obesity, but the observations have been discordant. This paper will discuss the current topics involving the influence of the sympathetic nervous system and β2- and β3-adrenoceptor polymorphisms in obesity.
authors: Nucleus Network, Ltd, Baker IDI Heart and Diabetes Research Institute, 89 Commercial Road, Melbourne, VIC 3004, Australia.
authors: Kazuko
authors: K
authors: Masuo
authors: Gavin W
authors: GW
authors: Lambert
references: Int J Obes Relat Metab Disord. 2002 May;26(5):633-9
references: 12032746
references: N Engl J Med. 2009 Apr 9;360(15):1509-17
references: 19357406
references: Hypertension. 2001 May;37(5):1303-8
references: 11358945
references: N Engl J Med. 2009 Jul 23;361(4):415-6; author reply 418-21
references: 19625723
references: Eur J Epidemiol. 2009;24(6):281-8
references: 19357973
references: MMWR Surveill Summ. 2008 Oct 31;57(11):1-20
references: 18971922
references: Clin Sci (Lond). 2005 Apr;108(4):323-9
references: 15574119
references: N Engl J Med. 1995 Aug 10;333(6):382-3
references: 7609759
references: Diabetes. 1996 Jan;45(1):15-22
references: 8522054
references: Am J Cardiol. 2001 Nov 1;88(9):1034-7
references: 11704005
references: Adv Data. 2004 Oct 27;(347):1-17
references: 15544194
references: Curr Hypertens Rep. 2008 Dec;10(6):440-7
references: 18959829
references: PLoS One. 2009 Sep 25;4(9):e7206
references: 19779622
references: Circulation. 2005 Jun 28;111(25):3429-34
references: 15956122
references: Diabetes Care. 1997 Dec;20(12):1887-90
references: 9405912
references: J Clin Invest. 1991 Jun;87(6):2246-52
references: 2040704
references: Hypertension. 2002 Jul;40(1):7-12
references: 12105130
references: Metabolism. 1982 Sep;31(9):896-9
references: 7121260
references: Hypertension. 1991 Dec;18(6):783-9
references: 1743759
references: Am J Hypertens. 1997 Jan;10(1):77-83
references: 9008251
references: Int J Obes Relat Metab Disord. 2000 Apr;24(4):443-9
references: 10805501
references: Hypertension. 2003 Oct;42(4):474-80
references: 12953019
references: Ann Med. 2004;36 Suppl 1:64-9
references: 15176426
references: Int J Obes Relat Metab Disord. 2001 Nov;25(11):1599-603
references: 11753577
references: Pharmacogenetics. 2004 Jun;14(6):343-9
references: 15247626
references: J Clin Invest. 1997 Dec 15;100(12):3005-13
references: 9399946
references: Am J Hypertens. 1996 Aug;9(8):739-45
references: 8862219
references: Metabolism. 1995 Sep;44(9 Suppl 3):15-7
references: 7674910
references: N Engl J Med. 2009 Aug 27;361(9):932-4
references: 19710497
references: Am J Clin Nutr. 2009 Jan;89(1):27-36
references: 19056585
references: Hypertension. 2010 Sep;56(3):351-8
references: 20625075
references: Am J Hypertens. 2001 Jun;14(6 Pt 1):530-8
references: 11411732
references: Eur Heart J. 2005 May;26(9):906-13
references: 15764611
references: JAMA. 2001 Sep 12;286(10):1195-200
references: 11559264
references: J Appl Physiol (1985). 2005 Mar;98(3):787-94
references: 15703163
references: Biochemistry. 1994 Aug 16;33(32):9414-9
references: 7915137
references: Am J Hypertens. 2005 Nov;18(11):1508-16
references: 16280290
references: Blood Press. 2001;10(4):199-204
references: 11800057
references: Circulation. 1998 May 26;97(20):2037-42
references: 9610534
references: Am J Physiol Endocrinol Metab. 2001 May;280(5):E740-4
references: 11287356
references: J Am Soc Nephrol. 2009 May;20(5):933-9
references: 18799718
references: JAMA. 2007 Nov 7;298(17):2028-37
references: 17986696
references: J Hypertens. 1993 Mar;11(3):319-25
references: 8387090
references: Diabetes. 1999 Jan;48(1):117-20
references: 9892231
references: J Hypertens. 2001 Mar;19(3 Pt 2):523-8
references: 11327624
references: Obes Res. 2005 Oct;13(10):1645-50
references: 16286511
references: Diabetes Care. 2001 Sep;24(9):1579-83
references: 11522702
references: J Ren Nutr. 2008 Jan;18(1):118-21
references: 18089457
references: N Engl J Med. 1995 Aug 10;333(6):352-4
references: 7609752
references: JAMA. 1979 May 11;241(19):2035-8
references: 430798
references: Circulation. 2001 Jul 10;104(2):187-90
references: 11447084
references: J Clin Endocrinol Metab. 2005 Nov;90(11):5998-6005
references: 16091482
references: Diabetologia. 2007 Mar;50(3):563-8
references: 17221209
references: Diabet Med. 2007 Apr;24(4):392-7
references: 17335470
references: J Hypertens. 2004 Oct;22(10):1999-2006
references: 15361773
references: Hypertension. 1999 Oct;34(4 Pt 2):724-8
references: 10523349
references: Hypertension. 2003 Oct;42(4):685-92
references: 12900437
references: Am Heart J. 2000 Mar;139(3):537-42
references: 10689270
references: Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E703-7
references: 16278251
references: JAMA. 1999 Oct 27;282(16):1519-22
references: 10546690
references: Int J Obes Relat Metab Disord. 2001 Nov;25(11):1604-8
references: 11753578
references: Diabetes Obes Metab. 2004 Nov;6(6):452-5
references: 15479221
references: N Engl J Med. 2001 Oct 4;345(14):1030-5
references: 11586955
references: Diabetes. 1998 Oct;47(10):1657-8
references: 9753308
references: Curr Diabetes Rev. 2010 Mar;6(2):58-67
references: 20034369
references: Am J Physiol Regul Integr Comp Physiol. 2007 May;292(5):R1834-8
references: 17218435
references: Hypertension. 1998 Jul;32(1):96-100
references: 9674644
references: Obes Res. 2005 Mar;13(3):519-26
references: 15833937
references: Brain Res Bull. 2003 Sep 30;61(5):511-9
references: 13679250
references: Hypertension. 2004 Apr;43(4):699-706
references: 14981063
references: Biol Pharm Bull. 2008 Feb;31(2):295-8
references: 18239290
references: Circulation. 2009 Apr 7;119(13):1728-35
references: 19307472
references: Am J Hypertens. 2006 Oct;19(10):1084-91
references: 17027833
references: Diabetes. 1999 Jan;48(1):203-5
references: 9892244
references: Lancet. 2009 Apr 11;373(9671):1275-81
references: 19332353
references: Acta Endocrinol (Copenh). 1983 Feb;102(2):252-7
references: 6338673
references: Obes Res. 2001 Dec;9(12):741-5
references: 11743057
references: Life Sci. 2002 Jun 21;71(5):537-46
references: 12052438
references: Hypertens Res. 2001 Jul;24(4):371-6
references: 11510749
references: Int J Mol Med. 2005 Oct;16(4):573-80
references: 16142389
references: Hypertens Res. 2007 Jun;30(6):503-11
references: 17664853
references: Hypertension. 2002 Sep;40(3):286-91
references: 12215468
references: J Clin Invest. 1993 Oct;92(4):1730-5
references: 8408625
references: Int J Obes Relat Metab Disord. 2002 Sep;26 Suppl 2:S28-38
references: 12174326
references: Hypertension. 1999 Jun;33(6):1425-30
references: 10373227
references: Am J Hypertens. 1989 Mar;2(3 Pt 2):125S-132S
references: 2647103
references: Am J Hypertens. 1989 Mar;2(3 Pt 2):140S-146S
references: 2647104
references: Hypertension. 2000 May;35(5):1135-40
references: 10818077
references: N Engl J Med. 2009 Jul 23;361(4):418; author reply 418-20
references: 19630145
references: Am J Hypertens. 2005 Jul;18(7):1009-14
references: 16054001
references: Int J Obes Relat Metab Disord. 1999 Oct;23(10):1099-100
references: 10557032
references: Diabetes. 2000 Dec;49(12):2149-53
references: 11118019
references: Exp Physiol. 2007 Sep;92(5):823-30
references: 17573413
references: Hypertens Res. 2006 Dec;29(12):951-9
references: 17378367
references: Am J Physiol. 1998 Dec;275(6):E909-16
references: 9843731
references: Pharmacol Ther. 2010 May;126(2):159-72
references: 20171982
references: Circulation. 2002 Mar 19;105(11):1354-9
references: 11901048
references: Kidney Int. 2001 Oct;60(4):1309-23
references: 11576345
references: Int J Obes (Lond). 2005 May;29(5):458-62
references: 15685248
references: Eur J Hum Genet. 2006 Jan;14(1):94-100
references: 16251889
references: Hypertension. 2000 Mar;35(3):807-13
references: 10720599
references: Int J Obes Relat Metab Disord. 2000 Mar;24(3):382-7
references: 10757635
references: Am J Hypertens. 1996 Nov;9(11):113S-120S
references: 8931844
references: J Hypertens. 2002 Feb;20(2):229-35
references: 11821707
references: Int J Obes Relat Metab Disord. 2004 Feb;28(2):185-90
references: 14610528
references: J Intern Med. 1999 Mar;245(3):253-9
references: 10205587
references: Int J Obes. 1981;5 suppl 1:79-91
references: 7239776
references: N Engl J Med. 1995 Aug 10;333(6):343-7
references: 7609750
references: Am J Physiol. 1993 Jan;264(1 Pt 1):E11-7
references: 8094272
references: Clin Endocrinol (Oxf). 2003 Oct;59(4):476-81
references: 14510910
references: Anat Rec. 1986 Apr;214(4):341-7
references: 3706779
references: J Clin Endocrinol Metab. 2005 Feb;90(2):1189-95
references: 15562022
references: Biochem J. 1989 Jul 1;261(1):1-10
references: 2570567
references: Q J Med. 1986 Dec;61(236):1081-90
references: 3310065